CardioPolymers Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

CardioPolymers General Information

Description

Developer of an implantable device for treating congestive heart failure. The company provides biocompatible polymer implant therapies to handle chronic heart failure, mitral valve regurgitation, and post-operative atrial fibrillation.

Contact Information

Formerly Known As
Symphony Medical, Rhythm Therapeutics Corp, Symphony Medical Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 26051 Merit Circle
  • Suite 104
  • Laguna Hills, CA 92653
  • United States
+1 (949)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Acquirer
Vertical(s)
Corporate Office
  • 26051 Merit Circle
  • Suite 104
  • Laguna Hills, CA 92653
  • United States
+1 (949)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CardioPolymers Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 02-Jun-2010 Completed Generating Revenue
6. Later Stage VC 20-Apr-2010 Completed Generating Revenue
5. Later Stage VC (Series C) 22-Jul-2009 Completed Generating Revenue
4. Later Stage VC 05-Sep-2008 Completed Generating Revenue
3. Early Stage VC (Series B) 17-Nov-2006 Completed Startup
2. Early Stage VC (Series A) 01-Jun-2004 $2.6M $3.2M Completed Startup
1. Early Stage VC (Series A1) 09-Sep-2002 $600K $600K Completed Startup
To view CardioPolymers’s complete valuation and funding history, request access »

CardioPolymers Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 2,888,889 $0.001000 $0.14 $1.8 $1.8 1x $1.8 3.41%
Series A1 625,000 $0.001000 $0.1 $1.2 $1.2 1x $1.2 0.74%
To view CardioPolymers’s complete cap table history, request access »

CardioPolymers Patents

CardioPolymers Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140275774-A1 Delivery catheter Inactive 15-Mar-2013
WO-2014145105-A2 Delivery catheter Inactive 15-Mar-2013
WO-2014145105-A3 Delivery catheter Inactive 15-Mar-2013
US-20140275773-A1 Delivery catheter for injecting a substrate into a tissue Inactive 15-Mar-2013
AU-2009289484-A1 Apparatus and method for capsule formation in tissue Active 05-Sep-2008 A61M25/1029
To view CardioPolymers’s complete patent history, request access »

CardioPolymers Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Domain Associates Venture Capital Minority
Fjord Ventures Venture Capital Minority
Johnson & Johnson JJDC Corporate Venture Capital Minority
Morgenthaler Venture Capital Minority
Saints Capital Secondary Buyer Minority
You’re viewing 5 of 6 investors. Get the full list »

CardioPolymers FAQs

  • When was CardioPolymers founded?

    CardioPolymers was founded in 2002.

  • Where is CardioPolymers headquartered?

    CardioPolymers is headquartered in Laguna Hills, CA.

  • What industry is CardioPolymers in?

    CardioPolymers’s primary industry is Therapeutic Devices.

  • Is CardioPolymers a private or public company?

    CardioPolymers is a Private company.

  • What is CardioPolymers’s current revenue?

    The current revenue for CardioPolymers is .

  • How much funding has CardioPolymers raised over time?

    CardioPolymers has raised $26.1M.

  • Who are CardioPolymers’s investors?

    Domain Associates, Fjord Ventures, Johnson & Johnson JJDC, Morgenthaler, and Saints Capital are 5 of 6 investors who have invested in CardioPolymers.

  • When was CardioPolymers acquired?

    CardioPolymers was acquired on 02-Jun-2010.

  • Who acquired CardioPolymers?

    CardioPolymers was acquired by LoneStar Heart.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process